Literature DB >> 19215695

Is long-term tocolysis effective for threatened premature labour?

K Takagi1, T Satoh.   

Abstract

There is some controversy regarding the optimum duration of tocolysis. This retrospective multicentre study was performed to evaluate whether long-term (> 2 days) tocolysis is effective in treating threatened premature labour. A total of 1147 eligible patients were grouped according to whether or not tocolytics were given, and according to route of administration and whether or not ritodrine (the standard tocolytic regimen in Japan) or other tocolytic was given. They were then further stratified into three subgroups, using the Baumgarten and Gruber tocolysis index (TI), to assess the efficacy of tocolysis treatment according to the risk of premature labour. Prolongation of gestation was significantly longer in patients treated with tocolytics for > 2 days compared with the unmedicated, bed-rest group. In women receiving tocolysis, the mean duration of prolonged gestation was 2.2 times longer in the intermediate-risk TI group and 3.1 times longer in the high-risk TI group compared with the unmedicated group. In the patients who received tocolysis, IV ritodrine was used in 86% of cases and was considered safe and effective for prolonging gestation in cases of threatened premature labour.

Entities:  

Mesh:

Year:  2009        PMID: 19215695     DOI: 10.1177/147323000903700128

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  7 in total

1.  Association between total dose of ritodrine hydrochloride and pulmonary oedema in twin pregnancy: a retrospective cohort study in Japan.

Authors:  Satoshi Shinohara; Rei Sunami; Yuzo Uchida; Shuji Hirata; Kohta Suzuki
Journal:  BMJ Open       Date:  2017-12-29       Impact factor: 2.692

2.  Incidence and risk factors of neonatal hypoglycemia after ritodrine therapy in premature labor: a retrospective cohort study.

Authors:  Shoko Shimokawa; Akiko Sakata; Yukio Suga; Kazuya Isoda; Shingo Itai; Katsuhiko Nagase; Tsutomu Shimada; Yoshimichi Sai
Journal:  J Pharm Health Care Sci       Date:  2019-04-16

3.  Synergic interaction between ritodrine and magnesium sulfate on the occurrence of critical neonatal hyperkalemia: A Japanese nationwide retrospective cohort study.

Authors:  Yukari Yada; Akihide Ohkuchi; Katsufumi Otsuki; Keiji Goishi; Mari Takahashi; Naohiro Yonemoto; Shigeru Saito; Satoshi Kusuda
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

4.  In utero exposure to ritodrine during pregnancy and risk of autism in their offspring until 8 years of age.

Authors:  Jungsoo Chae; Geum Joon Cho; Min-Jeong Oh; KeonVin Park; Sung Won Han; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

5.  Fetal biometric and Doppler measurements following abdominal radical trachelectomy in the second trimester of the pregnancy.

Authors:  Eiri Shima; Mina Itsukaichi; Kosuke Yoshihara; Tatsuya Ishiguro; Kazufumi Haino; Koji Nishino; Nobumichi Nishikawa; Koji Nishijima; Takayuki Enomoto
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-20       Impact factor: 3.105

6.  Evaluation of creatine kinase, lactate dehydrogenase, and amylase concentrations in umbilical blood of preterm infants after long-term tocolysis.

Authors:  Yoshiyuki Nakajima; Naoki Masaoka
Journal:  Obstet Gynecol Int       Date:  2014-02-13

7.  Maternal pulmonary edema after 46 h of ritodrine hydrochloride administration: A case report.

Authors:  Tsuyoshi Murata; Hyo Kyozuka; Aya Shiraiwa; Hirotaka Isogami; Toma Fukuda; Aya Kanno; Akiko Yamaguchi; Keiya Fujimori
Journal:  Case Rep Womens Health       Date:  2020-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.